COLOPLAST A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 837.4 DKK | +0.29% |
|
-0.92% | +8.47% |
| 12:34pm | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |  |
| 05-07 | European shares hit one-month high as earnings take centre stage | RE |
Presentation Operator MessageOperator (Operator)Welcome to the Coloplast interim financial sta...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
2024-08-20
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
835
DKK
Average target price
912.3
DKK
Spread / Average Target
+9.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.47% | 27.22B | |
| -29.43% | 3.14B | |
| -18.39% | 2.47B | |
| +12.41% | 2.35B | |
| +41.48% | 2.14B | |
| -1.23% | 2.03B | |
| +40.00% | 1.63B | |
| +5.74% | 1.34B | |
| +48.11% | 1.29B | |
| +9.30% | 1.19B |
- Stock Market
- Equities
- COLO B Stock
- News Coloplast A/S
- Transcript : Coloplast A/S, Nine Months 2022 Earnings Call, Aug 17, 2022